GlassScriptPhysician profile
Joseph A Moore
NPI 1750777959
$41,270.80
in general payments reported to CMS, 2019-2025
91 companies · $8,604 in 2025
The $8,604 reported for 2025 was more than what 79% of Medical Oncology providers received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.12 · 2020: $17.16 · 2021: $3,232 · 2022: $9,532 · 2023: $8,006 · 2024: $12K · 2025: $8,604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $12K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,620 · Education: $15.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,523.75 |
| Food and Beverage | $12,318.72 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,620.00 |
| Education | $15.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $8,210.12 | 2021-2025 | Enhertu, Vanflyta, Injectafer |
| Abbvie INC. | $2,612.74 | 2021-2025 | |
| Pfizer INC. | $2,482.19 | 2021-2025 | |
| Beigene USA, INC. | $2,352.75 | 2022-2024 | Brukinsa |
| Janssen Global Services, LLC | $2,200.00 | 2025 | |
| Servier Pharmaceuticals LLC | $1,871.46 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,686.79 | 2021-2025 | Imfinzi, Enhertu, Lynparza |
| Immunocore Limited | $1,621.18 | 2022-2025 | Kimmtrak |
| Taiho Oncology, INC. | $1,606.37 | 2022-2024 | |
| Gilead Sciences, INC. | $1,532.18 | 2021-2025 | Trodelvy |
| Geron Corporation | $960.00 | 2025 | Rytelo |
| Eagle Pharmaceuticals, INC. | $850.00 | 2022 | |
| Genzyme Corporation | $713.46 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $704.68 | 2021-2025 | |
| Emd Serono, INC. | $682.39 | 2021-2025 | Bavencio |
Show all 91 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $652.51 | 2021-2025 | Darzalex, Tecvayli, Talvey |
| Celgene Corporation | $580.84 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Verity Pharmaceuticals INC. | $500.00 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $453.20 | 2021-2025 | Opdivo, Opdualag |
| Regeneron Healthcare Solutions, INC. | $413.52 | 2021-2025 | Libtayo |
| Glaxosmithkline, LLC. | $389.72 | 2021-2025 | Ojjaara, Jemperli, Zejula |
| Merck Sharp & Dohme LLC | $389.18 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Lilly USA, LLC | $382.34 | 2021-2025 | Verzenio, Retevmo, Jaypirca |
| Genentech USA, INC. | $376.05 | 2023-2025 | Polivy, Tecentriq, Lunsumio |
| Amgen INC. | $367.56 | 2021-2023 | Blincyto, Kyprolis, Lumakras |
| Seagen INC. | $341.39 | 2021-2023 | Padcev, Tukysa, Adcetris |
| Exelixis INC. | $312.85 | 2022-2025 | Cabometyx |
| Aveo Pharmaceuticals, INC. | $270.00 | 2021-2025 | Fotivda |
| Eisai INC. | $250.47 | 2022-2025 | |
| Incyte Corporation | $246.05 | 2021-2025 | Monjuvi, Jakafi, Zynyz |
| Array Biopharma INC | $244.43 | 2021-2025 | Braftovi, Mektovi, Lorbrena |
| Alexion Pharmaceuticals, INC. | $232.05 | 2022-2025 | Ultomiris |
| Takeda Pharmaceuticals U.S.A., INC. | $228.60 | 2021-2025 | Alunbrig, Fruzaqla, Iclusig |
| Tersera Therapeutics LLC | $208.67 | 2021-2025 | Zoladex, Quzyttir, Xermelo |
| Genmab U.S., INC. | $202.91 | 2023-2025 | Tivdak, Epkinly |
| Pharmacyclics LLC, An Abbvie Company | $195.35 | 2021-2023 | Epkinly, Imbruvica |
| Ipsen Biopharmaceuticals, INC | $194.64 | 2022-2025 | Onivyde, Somatuline Depot, Tazverik |
| Adaptive Biotechnologies Corporation | $185.93 | 2022-2025 | Clonoseq |
| Jazz Pharmaceuticals INC. | $182.69 | 2022-2025 | |
| Astellas Pharma US INC | $177.47 | 2022-2025 | Xtandi, Xospata, Padcev |
| Rigel Pharmaceuticals, INC. | $176.23 | 2022-2025 | Rezlidhia, Gavreto, Tavalisse |
| Dendreon Pharmaceuticals LLC | $169.36 | 2021-2024 | Provenge |
| Apellis Pharmaceuticals, INC. | $163.88 | 2023-2025 | Empaveli |
| Sobi, INC | $158.40 | 2022-2025 | |
| Stemline Therapeutics INC. | $155.26 | 2023-2025 | Orserdu |
| Bayer Healthcare Pharmaceuticals INC. | $148.97 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $133.41 | 2024-2025 | Orgovyx |
| Deciphera Pharmaceuticals INC. | $109.87 | 2023-2025 | Qinlock |
| Avyxa Pharma, LLC | $100.88 | 2025 | |
| Kyowa Kirin, INC. | $95.00 | 2023-2025 | Poteligeo |
| Cti Biopharma Corp. | $91.77 | 2022-2023 | Vonjo |
| Sun Pharmaceutical Industries INC. | $84.23 | 2022-2024 | Odomzo, Yonsa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.41 | 2021-2025 | Gilotrif |
| Blue Earth Diagnostics | $80.84 | 2022-2025 | Posluma |
| Pharmacosmos Therapeutics INC. | $80.59 | 2024-2025 | Monoferric, Cosela |
| Tempus Ai, INC | $71.25 | 2025 | Xt Cdx |
| US Oncology Corporate, INC. | $69.93 | 2021 | |
| Spectrum Pharmaceuticals INC. | $69.47 | 2023-2025 | Rolvedon |
| Mirati Therapeutics, INC. | $64.21 | 2023-2024 | Krazati |
| Blueprint Medicines Corporation | $61.32 | 2022-2023 | Ayvakit |
| Acrotech Biopharma INC. | $60.89 | 2021-2025 | Beleodaq |
| Epizyme, INC. | $60.63 | 2021-2022 | |
| Kite Pharma, INC. | $59.14 | 2023-2025 | Yescarta |
| Iovance Biotherapeutics, INC. | $57.77 | 2024-2025 | Amtagvi |
| Springworks Therapeutics, INC. | $56.69 | 2024-2025 | Ogsiveo |
| Coherus Oncology, INC. | $55.81 | 2022-2025 | Udenyca |
| Octapharma USA, INC. | $53.35 | 2023-2025 | Octagam Immune Globulin (Human) |
| G1 Therapeutics, INC. | $51.30 | 2023 | Cosela |
| Recordati_rare_diseases_inc. | $42.31 | 2025 | Sylvant |
| Pharmaessentia USA Corporation | $41.96 | 2024-2025 | Besremi |
| Karyopharm Therapeutics INC. | $40.49 | 2022 | |
| Adc Therapeutics America, INC. | $39.58 | 2024 | |
| Azurity Pharmaceuticals, INC. | $38.31 | 2025 | Danziten |
| Agios Pharmaceuticals, INC. | $37.13 | 2023-2025 | Pyrukynd |
| Celltrion USA INC. | $34.65 | 2024 | Vegzelma |
| Mylan Institutional INC. | $31.55 | 2022-2023 | Fulphila, Ogivri |
| Morphosys, US INC. | $29.39 | 2022-2023 | Monjuvi |
| Myriad Genetic Laboratories, INC. | $26.85 | 2023-2024 | Myrisk |
| Legend Biotech USA INC. | $25.13 | 2025 | Carvykti |
| Novocure INC. | $21.61 | 2024 | Optune Lua (Novottf-200t) |
| Secura Bio, INC. | $20.50 | 2025 | Copiktra |
| Accord Healthcare, INC. | $19.24 | 2025 | |
| Caris Mpi, INC. | $18.76 | 2025 | Mi Cancer Seek |
| Syndax Pharmaceuticals, INC. | $17.15 | 2025 | |
| Janssen Pharmaceuticals, INC | $15.99 | 2025 | |
| Amneal Pharmaceuticals LLC | $15.79 | 2025 | Alymsys |
| Foundation Medicine, INC. | $15.77 | 2022 | |
| Clovis Oncology, INC. | $13.80 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $12.66 | 2022 | |
| Acceleron Pharma, INC. | $12.39 | 2021 | |
| Dova Pharmaceuticals | $11.20 | 2021 |
Drugs and devices associated with these payments
Enhertu $4,644Brukinsa $2,275Tibsovo $1,757Padcev $1,731Lonsurf $1,581Trodelvy $1,329Rytelo $960Imfinzi $906Epkinly $481Imbruvica $473Sarclisa $380Venclexta $331Libtayo $302Cabometyx $282Ibrance $254Verzenio $244Orgovyx $243Darzalex $228Reblozyl $220Xtandi $218Keytruda $216Tecvayli $215Lenvima $214Tukysa $212Fotivda $198Adcetris $196Elrexfio $190Braftovi $190Mektovi $190Bavencio $189Ultomiris $180Opdivo $167Rezlidhia $163Tavalisse $163Jevtana $163Zepzelca $162Talvey $157Orserdu $155Rybrevant $155Clonoseq $153Lynparza $151Lorbrena $148Empaveli $146Kisqali $145Monjuvi $144Ojjaara $142Talzenna $135Polivy $129Scemblix $127Carvykti $122Onivyde $120Tivdak $118Tecentriq $112Qinlock $110Bosulif $105Zoladex $102Pomalyst $98.64Provenge $97.07Poteligeo $95.00Lunsumio $93.44Cosela $90.81Elahere $89.46Gavreto $86.85Zejula $85.04Jemperli $85.04Blincyto $81.82Kyprolis $77.92Posfrea $77.74Axtle $77.74Frindovyx $77.74Doptelet $77.44Fabhalta $75.42Alunbrig $74.49Nubeqa $73.63Comirnaty $71.98Xt Cdx $71.25Columvi $70.88Rolvedon $69.47Krazati $64.21Yonsa $63.64Odomzo $63.64Welireg $63.59Docivyx $62.99Elitek $62.96Posluma $62.73Fruzaqla $61.56Phesgo $61.04Lumakras $59.83Lutathera $58.75Amtagvi $57.77Paxlovid $57.72Jakafi $57.47Ogsiveo $56.69Vitrakvi $55.06Stivarga $55.06Octagam Immune Globulin (Human) $53.35Inlyta $52.37Xalkori $50.26Iclusig $48.76Vonjo $46.96
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.